Objective: This study evaluates surgical outcomes in benign prostatic hyperplasia (BPH) patients undergoing transurethral enucleation using various holmium laser (HoLEP) settings and/or bipolar devices (BipoLEP).
Design: This study was retrospective.
Methods: We retrospectively analyzed 158 BPH patients treated surgically, categorized by method: BipoLEP ( = 28), HoLEP with short pulse (HoLEP-SP, = 26), HoLEP with long pulse and low energy (HoLEP-LP/LE, = 29), HoLEP with long pulse and high energy (HoLEP-LP/HE, = 26), HoLEP using Moses technology (HoLEP-Mo, = 19), and a combination of HoLEP and BipoLEP (HoLEP-mix, = 30).